Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancer
Authors:
- William G. RichardsWRWilliam G. Richards
- James E. HerndonJHJames E. Herndon
- David J. SugarbakerDSDavid J. Sugarbaker
- 1 May 1996
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 61 (5) , 1470-1476
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrenceCancer, 1995
- Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung.Journal of Clinical Oncology, 1995
- Prognostic Significance of the Proliferation Index in Surgically Resected Non—Small-Cell Lung CancerArchives of Surgery, 1993
- Relation of neovascularisation to metastasis of non-small-cell lung cancerThe Lancet, 1992
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- Cancer recurrence after resection: T1 N0 non-small cell lung cancerThe Annals of Thoracic Surgery, 1990
- Flexible regression models with cubic splinesStatistics in Medicine, 1989
- A New International Staging System for Lung CancerChest, 1986
- Postsurgical Stage I Bronchogenic Carcinoma: Morbid Implications of Recurrent DiseaseThe Annals of Thoracic Surgery, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958